Meibomian gland dysfunction Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting meibomian gland dysfunction clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Auckland, New Zealand, Berkeley, California, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Meibomian gland dysfunction Trials at a Glance

8 actively recruiting trials for meibomian gland dysfunction are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Auckland, Berkeley, and Birmingham. Lead sponsors running meibomian gland dysfunction studies include Singapore National Eye Centre, The University of Hong Kong, and Aston University.

Browse meibomian gland dysfunction trials by phase

Treatments under study

About Meibomian gland dysfunction Clinical Trials

Looking for clinical trials for Meibomian gland dysfunction? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Meibomian gland dysfunction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Meibomian gland dysfunction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction (MGD)
University of Alabama at Birmingham48 enrolled1 locationNCT07224529
Recruiting
Phase 4

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

Dry EyeMeibomian gland dysfunction
University of California, Berkeley65 enrolled1 locationNCT07606625
Recruiting
Not Applicable

Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction

Meibomian gland dysfunction
Universidad Autonoma de Nuevo Leon42 enrolled1 locationNCT03767530
Recruiting
Not Applicable

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Dry Eye SyndromesMeibomian gland dysfunction
The University of Hong Kong112 enrolled2 locationsNCT06220474
Recruiting
Not Applicable

Photobiomodulation With REd vs BluE Light (REBEL)

Dry Eye SyndromesMeibomian gland dysfunctionBlepharitis
Aston University36 enrolled2 locationsNCT06371300
Recruiting

Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy

Dry EyeMeibomian Gland Dysfunction (Disorder)
Singapore National Eye Centre30 enrolled1 locationNCT07329712
Recruiting
Not Applicable

Low Level Light Therapy & Skin Pigmentation

Dry EyeMeibomian Gland Dysfunction (Disorder)
University of Houston40 enrolled1 locationNCT07173530
Recruiting

Evaluation of a new biomarker for tear film health

Aqueous-deficient dry eyeMeibomian gland dysfunction
The University of Melbourne60 enrolled1 locationACTRN12625000028404